Hemin activation abrogates Mycoplasma hyorhinis replication in chronically infected prostate cancer cells via heme oxygenase‐1 induction

• Main Authors: Hanxia Huang, Alena Dabrazhynetskaya, Jacob Pluznik, Jiwen Zheng, Yong Wu, Vladimir Chizhikov, Paul W. Buehler, Kenneth M. Yamada, Subhash Dhawan
• Format: Article
• Language: English
• Published: Wiley 2021-10-01
• Series: FEBS Open Bio
• Subjects: heme oxygenase‐1; host defense; infectious disease; innate immunity; Mycoplasma hyorhinis; prostate cancer
• Online Access: https://doi.org/10.1002/2211-5463.13271
• ISSN: 2211-5463

Mycoplasma hyorhinis (M. hyorhinis) lacks a cell wall and resists multiple antibiotics. We describe here the striking > 90% inhibitory effect of hemin, a natural inducer of the cytoprotective enzyme heme oxygenase‐1 (HO‐1), on M. hyorhinis replication in chronically infected LNCaP prostate cancer cells. The role of HO‐1 in interrupting M. hyorhinis replication was confirmed by HO‐1‐specific siRNA suppression of hemin‐induced HO‐1 protein expression, which increased intracellular M. hyorhinis DNA levels in LNCaP cells. Proteomic analysis and transmission electron microscopy of hemin‐treated cells confirmed the complete absence of M. hyorhinis proteins and intact microorganisms, respectively, strongly supporting these findings. Our study is the first to our knowledge suggesting therapeutic potential for activated HO‐1 in cellular innate responses against mycoplasma infection.